Bibliography

Found 1068 results
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Z
Shapshak P, Somboonwit C, Foley BT, Alraaba SF, Wills T, Sinnott JT, Kuhn J. Zika Virus. In: Global Virology I. Identifying and investigating viral diseases. Global Virology I. Identifying and investigating viral diseases. New York: Springer Publ.; 2015. pp. 477-500.
X
Somboonwit C, Sinnott JT, Shapshak P, Kuhn J, Sinnott JT. XMRV: Emerging human infection or false alarm in Global Virology I. Identifying and investigating viral diseases. In: Global Virology I. Identifying and investigating viral diseases. Global Virology I. Identifying and investigating viral diseases. New York: Springer Publ.; 2015. pp. 561-574.
W
Shi Y, Shu J, Gelman B, Lisinicchia JG, Tang S-J. Wnt signaling in the pathogenesis of human HIV-associated pain syndromes. Journal of neuroimmune pharmacology: the official journal of the Society on NeuroImmune Pharmacology [Internet]. 2013 ;8(4):956-64. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23737037
DeBoever C, Reid EG, Smith EN, Wang X, Dumaop W, Harismendy O, Carson D, Richman D, Masliah E, Frazer KA. Whole transcriptome sequencing enables discovery and analysis of viruses in archived primary central nervous system lymphomas. PLoS One. 2013 ;8(9):e73956.
Gongvatana A, Schweinsburg BC, Taylor MJ, Theilmann RJ, Letendre SL, Alhassoon OM, Jacobus J, Woods SP, Jernigan TL, Ellis RJ, et al. White matter tract injury and cognitive impairment in human immunodeficiency virus-infected individuals. J Neurovirol. 2009 ;15(2):187-95.
Alakkas A, Ellis RJ, Watson CWei-Ming, Umlauf A, Heaton RK, Letendre S, Collier A, Marra C, Clifford DB, Gelman B, et al. White matter damage, neuroinflammation, and neuronal integrity in HAND. J Neurovirol. 2019 ;25(1):32-41.
Solomon IH, Chettimada S, Misra V, Lorenz DR, Gorelick RJ, Gelman BB, Morgello S, Gabuzda D. White Matter Abnormalities Linked to Interferon, Stress Response, and Energy Metabolism Gene Expression Changes in Older HIV-Positive Patients on Antiretroviral Therapy. Mol Neurobiol. 2020 ;57(2):1115-1130.
Gelman BB, Endsley J, Kolson D. When do models of NeuroAIDS faithfully imitate "the real thing"?. J Neurovirol. 2018 ;24(2):146-155.
Alraaba SF, Somboonwit C, Shapshak P, Kuhn J, Sinnott JT. West Nile Virus in Global Virology I. Identifying and investigating viral diseases. In: Global Virology I. Identifying and investigating viral diseases. Global Virology I. Identifying and investigating viral diseases. New York: Springer Publ.; 2015.
Levine AJ, Miller JS, Horvath S, Gelman B. Weighted gene co-expression network analysis of NeuroAIDS cognitive disorders. In: Summit on Systems Biology. Summit on Systems Biology. Richmond, VA; 2011.
V
Moody AL, Morgello S, Gerits P, Byrd D. Vulnerabilities and caregiving in an ethnically diverse HIV-infected population. AIDS and Behavior [Internet]. 2009 ;13:337-347. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17876698
Fujimura RK, Shapshak P, Segal DM, Crandall KA, Goodkin K, Page JB, Douyon R, Zhang BT, Xin KQ, P de la Vega R, et al. Viral and host determinants of neurovirulence of HIV-1 infection. Adv Exp Med Biol. 1998 ;437:241-53.
Marquine MJ, Montoya JL, Umlauf A, Fazeli PL, Gouaux B, Heaton RK, Ellis RJ, Letendre SL, Grant I, Moore DJ. The Veterans Aging Cohort Study (VACS) Index and Neurocognitive Change: A Longitudinal Study. Clin Infect Dis. 2016 ;63(5):694-702.
Marquine MJ, Umlauf A, Rooney AS, Fazeli PL, Gouaux BD, Woods SPaul, Letendre SL, Ellis RJ, Grant I, Moore DJ. The veterans aging cohort study index is associated with concurrent risk for neurocognitive impairment. J Acquir Immune Defic Syndr. 2014 ;65(2):190-7.
Guha D, Misra V, Yin J, Horiguchi M, Uno H, Gabuzda D. Vascular injury markers associated with cognitive impairment in people with HIV on suppressive antiretroviral therapy. AIDS. 2023 ;37(14):2137-2147.
Dawes S, Suarez P, Casey CY, Cherner M, Marcotte TD, Letendre S, Grant I, Heaton RK. Variable patterns of neuropsychological performance in HIV-1 infection. Journal of Clinical and Experimental Neuropsychology [Internet]. 2008 ;30:613-26. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18608689
Cherner M, Masliah E, Heaton RK, Ellis RJ, Grant I, HNRC. Value of neurocognitive status in predicting HIV-related brain disease. In: Journal of the International Neuropsychological Society. Vol. 7. Journal of the International Neuropsychological Society. ; 2001. p. 150.
Letendre S, Marquie-Beck J, Capparelli E, Best B, Clifford D, Collier AC, Gelman BB, McArthur JC, J McCutchan A, Morgello S, et al. Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch Neurol. 2008 ;65(1):65-70.
Marquie-Beck J, Ellis RJ, Langford D, Childers ME, Rippeth JD, Letendre S, Lazzaretto D, Masliah E. Validation of post-mortem CSF viral load by comparison to ante-mortem viral load and clinical measurements. In: Journal of NeuroVirology. Vol. 9. Journal of NeuroVirology. ; 2003. p. 130.
Robinson-Papp J, Nmashie A, Pedowitz E, Benn EKT, George MCatherine, Sharma S, Murray J, Machac J, Heiba S, Mehandru S, et al. Vagal dysfunction and small intestinal bacterial overgrowth: novel pathways to chronic inflammation in HIV. AIDS. 2018 ;32(9):1147-1156.

Pages